Xinyan Hao

698 total citations · 1 hit paper
19 papers, 468 citations indexed

About

Xinyan Hao is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Xinyan Hao has authored 19 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Biomedical Engineering. Recurrent topics in Xinyan Hao's work include Nanoplatforms for cancer theranostics (7 papers), Immunotherapy and Immune Responses (5 papers) and Extracellular vesicles in disease (4 papers). Xinyan Hao is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), Immunotherapy and Immune Responses (5 papers) and Extracellular vesicles in disease (4 papers). Xinyan Hao collaborates with scholars based in China, India and Ireland. Xinyan Hao's co-authors include Junyong Wu, Daxiong Xiang, Yongjiang Li, Wenjie Xu, Min Zhou, Si Huang, Xun Sun, Zhirong Zhang, Hairui Wang and Chao Tu and has published in prestigious journals such as Nature Communications, Nano Letters and Advanced Functional Materials.

In The Last Decade

Xinyan Hao

18 papers receiving 466 citations

Hit Papers

Nanomaterials for bone metastasis 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinyan Hao China 10 225 123 106 54 51 19 468
Sumita Behera United States 10 261 1.2× 90 0.7× 100 0.9× 135 2.5× 58 1.1× 14 672
Katharina Czaja Germany 14 154 0.7× 203 1.7× 96 0.9× 90 1.7× 84 1.6× 20 953
Annika Frede Germany 13 282 1.3× 186 1.5× 110 1.0× 74 1.4× 31 0.6× 17 611
Yina Wu South Korea 13 198 0.9× 170 1.4× 135 1.3× 60 1.1× 22 0.4× 18 428
Haoyu Tang China 12 351 1.6× 95 0.8× 126 1.2× 140 2.6× 42 0.8× 20 596
Hasan Akbaba Türkiye 11 222 1.0× 106 0.9× 157 1.5× 170 3.1× 42 0.8× 34 556
Xuemeng Guo China 12 218 1.0× 221 1.8× 242 2.3× 73 1.4× 56 1.1× 28 584
Wuji Cao United States 9 346 1.5× 95 0.8× 156 1.5× 174 3.2× 62 1.2× 10 593
Hongbing Lin China 10 158 0.7× 53 0.4× 100 0.9× 46 0.9× 36 0.7× 20 461

Countries citing papers authored by Xinyan Hao

Since Specialization
Citations

This map shows the geographic impact of Xinyan Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyan Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyan Hao more than expected).

Fields of papers citing papers by Xinyan Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyan Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyan Hao. The network helps show where Xinyan Hao may publish in the future.

Co-authorship network of co-authors of Xinyan Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyan Hao. A scholar is included among the top collaborators of Xinyan Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyan Hao. Xinyan Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Han, Ruyue, Hui Zhou, Wenjie Xu, et al.. (2025). Biomimetic self-assembly nanoparticles inhibit serpinB9 and synergistically enhance COD-induced ferroptosis for cancer therapy. Materials Today Bio. 33. 101982–101982.
2.
Hao, Xinyan, Yucheng Tang, Wenjie Xu, et al.. (2025). Engineered biomimetic cisplatin-polyphenol nanocomplex for chemo-immunotherapy of glioblastoma by inducing pyroptosis. Journal of Nanobiotechnology. 23(1). 14–14. 6 indexed citations
3.
Zhou, Min, Ruyue Han, Wenjie Xu, et al.. (2025). Biomimetic Atorvastatin Self-Assembled Nanomedicine Inhibits the Cyclooxygenase-2/Prostaglandin E2 Pathway Enhanced Photothermal and Antitumor Immunity. Biomaterials Research. 29. 149–149. 2 indexed citations
4.
Liu, Lei, Xinyan Hao, Yang Wang, et al.. (2024). Coronavirus envelope protein activates TMED10-mediated unconventional secretion of inflammatory factors. Nature Communications. 15(1). 8708–8708. 7 indexed citations
5.
Wu, Junyong, Xinyan Hao, Lin Qi, et al.. (2024). Assembly of a biomimetic copper-based nanocomplex for alleviating hypoxia to enhance cuproptosis against osteosarcoma and lung metastasis. Acta Biomaterialia. 193. 348–361. 5 indexed citations
6.
Hao, Xinyan, Junyong Wu, Daxiong Xiang, et al.. (2024). Nanomaterials for bone metastasis. Journal of Controlled Release. 373. 640–651. 89 indexed citations breakdown →
7.
Huang, Si, Yongjiang Li, Junyong Wu, et al.. (2024). Biomimetic nanodecoys deliver cholesterol-modified heteroduplex oligonucleotide to target dopaminergic neurons for the treatment of Parkinson's disease. Acta Biomaterialia. 177. 316–331. 6 indexed citations
8.
Xu, Wenjie, Yucheng Tang, Jingjing Tian, et al.. (2024). Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer. Journal of Nanobiotechnology. 22(1). 798–798. 9 indexed citations
9.
Xu, Wenjie, Xinyan Hao, Yongjiang Li, et al.. (2024). Safe Induction of Acute Inflammation with Enhanced Antitumor Immunity by Hydrogel‐Mediated Outer Membrane Vesicle Delivery. Small Methods. 8(10). e2301620–e2301620. 11 indexed citations
10.
Zhou, Min, Yucheng Tang, Wenjie Xu, et al.. (2023). Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies. Frontiers in Immunology. 14. 1140463–1140463. 36 indexed citations
11.
Zhou, Min, Yongjiang Li, Xinyan Hao, et al.. (2022). Apoptotic bodies for advanced drug delivery and therapy. Journal of Controlled Release. 351. 394–406. 86 indexed citations
12.
Chen, Zhengjun, Xinyan Hao, Hairui Wang, et al.. (2022). Smart combination of aluminum hydroxide and MF59 to induce strong cellular immune responses. Journal of Controlled Release. 349. 699–711. 27 indexed citations
13.
Hao, Xinyan, Junyong Wu, Daxiong Xiang, & Yong‐Yu Yang. (2022). Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years. Frontiers in Pharmacology. 13. 846715–846715. 6 indexed citations
14.
Huang, Si, Xinyan Hao, Yongjiang Li, et al.. (2022). Nonviral delivery systems for antisense oligonucleotide therapeutics. Biomaterials Research. 26(1). 49–49. 35 indexed citations
15.
Li, Chenglong, Xiaohong Chen, Hairui Wang, et al.. (2021). Nanoemulsions Target to Ectopic Lymphoids in Inflamed Joints to Restore Immune Tolerance in Rheumatoid Arthritis. Nano Letters. 21(6). 2551–2561. 50 indexed citations
16.
Hao, Xinyan, Xiaofang Zhong, & Xun Sun. (2021). The effects of all-trans retinoic acid on immune cells and its formulation design for vaccines. The AAPS Journal. 23(2). 32–32. 14 indexed citations
17.
Zhong, Xiaofang, Guangsheng Du, Xuanyu Wang, et al.. (2021). Nanovaccines Mediated Subcutis‐to‐Intestine Cascade for Improved Protection against Intestinal Infections. Small. 18(1). e2105530–e2105530. 17 indexed citations
18.
Zhang, Yuandong, Haibo Li, Qin Wang, et al.. (2018). Rationally Designed Self‐Assembling Nanoparticles to Overcome Mucus and Epithelium Transport Barriers for Oral Vaccines against Helicobacter pylori. Advanced Functional Materials. 28(33). 54 indexed citations
19.
Wang, Jun, et al.. (2014). miRNAs expression profile in bast of ramie elongation phase and cell wall thickening and end wall dissolving phase. Molecular Biology Reports. 41(2). 901–907. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026